STEM CELL TRANSPLANT BETTER THAN BONE MARROW TRANSPLANT FOR
SOME LEUKEMIAS Preliminary results from a 3-year study of 168 patients with
high-risk blood and immune system cancers show that those who received stem
cell transplants had a survival advantage over those who received
standard treatment with bone marrow transplantation. http://oncology.medscape.com/14872.rhtml <a
href="http://oncology.medscape.com/14872.rhtml">Read it
Here</a>